CIK: 0001193586 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $324,566 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PCTY | Paylocity Holding Corporation | 568,412 | $93,703 | 28.9% | $27.51 | +512.1% | Common | 70438V106 |
| RMNI | Rimini Street, Inc. | 23,565,433 | $77,059 | 23.7% | $8.44 | -67.5% | Common | 76674Q107 |
| COIN | Coinbase Global, Inc. | 238,149 | $41,419 | 12.8% | $109.20 | 0.0% | Common- Class A | 19260Q107 |
| QTWO | Q2 Holdings, Inc. | 777,562 | $33,754 | 10.4% | $19.72 | +80.2% | Common | 74736L109 |
| — | Fusion Pharmaceuticals, Inc. | 2,947,809 | $28,328 | 8.7% | $15.72 | — | Common | 36118A100 |
| MLYS | Mineralys Therapeutics, Inc. | 2,302,329 | $19,800 | 6.1% | $16.83 | -53.4% | Common | 603170101 |
| PATH | UiPath, Inc. | 539,111 | $13,392 | 4.1% | $18.78 | +3.9% | Common- Class A | 90364P105 |
| — | Vacasa, Inc. | 938,225 | $7,693 | 2.4% | $6.75 | — | Common- Class A | 91854V107 |
| CRVS | Corvus Pharmaceuticals, Inc. | 3,275,616 | $5,765 | 1.8% | $13.47 | -89.1% | Common | 221015100 |
| BZ | Kanzhun Limited | 94,809 | $1,575 | 0.5% | $16.61 | — | ADS | 48553T106 |
| MIRM | Mirum Pharmaceuticals, Inc. | 32,627 | $963 | 0.3% | $30.26 | 0.0% | Common | 604749101 |
| — | Couchbase, Inc. | 26,557 | $598 | 0.2% | $22.52 | — | Common | 22207T101 |
| UBER | Uber Technologies, Inc. | 4,756 | $293 | 0.1% | $52.31 | 0.0% | Common | 90353T100 |
| QS | Quantumscape Corp | 32,313 | $225 | 0.1% | $6.30 | 0.0% | Common- Class A | 74767V109 |